Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study

Fig. 3

Association between the mean HbA1c value from all visits and the risk of primary outcome and all-cause mortality. A & B: Among all participants. C & D: Comparison among different HbA1c variability groups. The solid red line represents the estimated hazard ratio, while the dotted blue line indicates the 95% confidence interval

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840